I
Immunovant, Inc. Common StockIMVT
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune.
US StocksBiotechnologyHealthcareMid Cap
IMVT の価格トレンド
Immunovant, Inc. Common Stock · TradingView フルチャート
NASDAQ:IMVT